Cogent Biosciences, Inc. COGT Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $312.01M+218% | $98.17M+84.4% | $53.23M-61.9% | $139.89M-36.3% | ||
| $588.75M+212% | $188.91M-11.1% | $212.48M+78.0% | $119.39M— | ||
| $910.36M+207% | $296.47M+9.5% | $270.77M+2.2% | $264.97M+19.0% | ||
| $5.46M-15.6% | $6.47M-22.5% | $8.34M+7.2% | $7.78M+356% | ||
| $937.61M+186% | $327.9M+4.6% | $313.44M+4.2% | $300.81M+29.6% | ||
| $9.5M-20.9% | $12.01M+12.7% | $10.66M+82.4% | $5.84M+67.7% | ||
| $63.95M+14.8% | $55.71M+46.0% | $38.17M+42.2% | $26.85M+57.2% | ||
| $301.24M+321% | $71.61M+28.7% | $55.64M+23.4% | $45.08M+152% | ||
| $161K+46.4% | $110K+27.9% | $86K+22.9% | $70K+59.1% | ||
| -$1.19B-38.3% | -$859.48M-42.4% | -$603.62M-46.8% | -$411.21M-51.8% | ||
| $636.37M+148% | $256.29M-0.6% | $257.8M+0.8% | $255.74M+19.4% | ||
| $937.61M+186% | $327.9M+4.6% | $313.44M+4.2% | $300.81M+29.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Cogent Biosciences, Inc.'s total assets?
- Cogent Biosciences, Inc. (COGT) holds $903.0M in total assets, up 218.2% year over year.
- How much debt does Cogent Biosciences, Inc. have?
- Cogent Biosciences, Inc. carries $15.5M in total debt against $607.7M of shareholders' equity, a debt-to-equity ratio of 0.03.
- How much cash does Cogent Biosciences, Inc. have?
- Cogent Biosciences, Inc. holds $241.2M in cash and equivalents.
- Can Cogent Biosciences, Inc. cover its short-term obligations?
- Its current ratio is 15.14 — current assets exceed current liabilities.
- Where does Cogent Biosciences, Inc.'s balance sheet data come from?
- Every line is extracted from Cogent Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
